The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
Open accessAbstract
Alcohol dependence is a disease that impacts millions of individuals worldwide. There has been some progress with pharmacotherapy for alcohol-dependent individuals; however, there remains a critical need for the development of novel and additional therapeutic approaches. Alcohol and nicotine are commonly abused together, and there is evidence that neuronal nicotinic acetylcholine receptors (nAChRs) play a role in both alcohol and nicotine dependence. Varenicline, a partial agonist at the α4β2 nAChRs, reduces nicotine intake and was recently approved as a smoking cessation aid. We have investigated the role of varenicline in the modulation of ethanol consumption and seeking using three different animal models of drinking. We show that acute administration of varenicline, in doses reported to reduce nicotine reward, selectively reduced ethanol but not sucrose seeking using an operant self-administration drinking paradigm and also decreased voluntary ethanol but not water consumption in animals chronically exposed to ethanol for 2 months before varenicline treatment. Furthermore, chronic varenicline administration decreased ethanol consumption, which did not result in a rebound increase in ethanol intake when the varenicline was no longer administered. The data suggest that the α4β2 nAChRs may play a role in ethanol-seeking behaviors in animals chronically exposed to ethanol. The selectivity of varenicline in decreasing ethanol consumption combined with its reported safety profile and mild side effects in humans suggest that varenicline may prove to be a treatment for alcohol dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880
Tonstad, S. (2006) · JAMA · doi:10.1001/jama.296.1.64 · Cited by 660
Samson, H. H. (1986) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1986.tb05120.x · Cited by 652
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558
Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533
Nicotinic receptors in the brain: correlating physiology with function
Jones, S., Sudweeks, S., & Yakel, J. L. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01471-x · Cited by 450
Rollema, H., Coe, J. W., Chambers, L. K., Hurst, R. S., Stahl, S. M., & Williams, K. E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.05.003 · Cited by 400
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387
Nicotine addiction and comorbidity with alcohol abuse and mental illness
Dani, J. A., & Harris, R. A. (2005) · Nature Neuroscience · doi:10.1038/nn1580 · Cited by 382
Voluntary ethanol intake in rats following exposure to ethanol on various schedules
Wise, R. A. (1973) · Psychopharmacologia · doi:10.1007/bf00414034 · Cited by 382
Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J.-P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 343
Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference
Froehlich, J. C., Harts, J., Lumeng, L., & Li, T.-K. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90174-g · Cited by 296
Blomqvist, O., Ericson, M., Johnson, D. H., Engel, J. A., & Söderpalm, B. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00583-3 · Cited by 236
Involvement of Nicotinic Receptors in Alcohol Self‐Administration
Lě, A. D., Corrigall, W. A., Watchus, J., Harding, S., Juzytsch, W., & Li, T. ‐. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04585.x · Cited by 202
Obach, R. S., Reed-Hagen, A. E., Krueger, S. S., Obach, B. J., O’Connell, T. N., Zandi, K. S., Miller, S., & Coe, J. W. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006767 · Cited by 200
Cardoso, R. A., Brozowski, S. J., Chavez-Noriega, L. E., Harpold, M., Valenzuela, C. F., & Harris, R. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38200-x · Cited by 192
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 191
Ericson, M., Blomqvist, O., Engel, J. A., & Söderpalm, B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00602-5 · Cited by 187
A double-blind study evaluating the long-term safety of varenicline for smoking cessation
Williams, K. E., Reeves, K. R., Billing, C. B., Pennington, A. M., & Gong, J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x182185 · Cited by 184
Tizabi, Y., Copeland, R. L., Louis, V. A., & Taylor, R. E. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200203000-00014 · Cited by 181
Accumbal dopamine overflow after ethanol: Localization of the antagonizing effect of mecamylamine
Blomqvist, O., Ericson, M., Engel, J. A., & Söderpalm, B. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01220-x · Cited by 170
The Status of Naltrexone in the Treatment of Alcohol Dependence: Specific Effects on Heavy Drinking
Pettinati, H. M., O'Brien, C. P., Rabinowitz, A. R., Wortman, S. P., Oslin, D. W., Kampman, K. M., & Dackis, C. A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000245566.52401.20 · Cited by 169
Ericson, M., Molander, A., Löf, E., Engel, J. A., & Söderpalm, B. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01564-4 · Cited by 168
Ethanol Modulation of Nicotinic Acetylcholine Receptor Currents in Cultured Cortical Neurons
Aistrup, G. L., Marszalec, W., & Narahashi, T. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.1.39 · Cited by 148
Heavy consumption of cigarettes, alcohol and coffee in male twins.
Swan, G. E., Carmelli, D., & Cardon, L. R. (1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.182 · Cited by 145
Naltrexone as an Adjunctive Treatment for Older Patients With Alcohol Dependence
Oslin, D. W., Liberto, J. G., O'Brien, J. T., Krois, S., & Norbeck, J. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00007 · Cited by 143
Larsson, A. C., EDSTRÖM, L., Svensson, L., Söderpalm, B., & Engel, J. A. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh180 · Cited by 138
Neuronal nicotinic acetylcholine receptors: a new target site of ethanol
Narahashi, T., Aistrup, G. L., Marszalec, W., & Nagata, K. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00055-8 · Cited by 135
Larsson, A. C., Svensson, L., Söderpalm, B., & Engel, J. A. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00244-6 · Cited by 132
Alcohol's actions on neuronal nicotinic acetylcholine receptors.
Davis, T. J., & de Fiebre, C. M. (2006) · PubMed Central · Cited by 115
Ciccocioppo, R., Lin, D. C.-H., Martin‐Fardon, R., & Weiss, F. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1380-z · Cited by 103
Mecamylamine Attenuates the Subjective Stimulant‐Like Effects of Alcohol in Social Drinkers
Chi, H., & de Wit, H. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000065435.12068.24 · Cited by 101
Anton, R. F., Moak, D. H., Latham, P. K., Waid, L. R., Malcolm, R. J., Dias, J. K., & Roberts, J. S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00013 · Cited by 90
Beczkowska, I. W., Bowen, W. D., & Bodnar, R. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)91289-q · Cited by 88
Mecamylamine Modifies the Pharmacokinetics and Reinforcing Effects of Alcohol
Blomqvist, O., Hernández–Ávila, C. A., Kirk, J. V., Rose, J. E., & Kranzler, H. R. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02541.x · Cited by 82
Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption
Stromberg, M. F., Mackler, S. A., Volpicelli, J. R., & O’Brien, C. P. (2001) · Alcohol · doi:10.1016/s0741-8329(00)00137-3 · Cited by 81
Rezvani, A. H., Overstreet, D. H., Yang, Y., Maisonneuve, I. M., Bandarage, U. K., Kuehne, M. E., & Glick, S. D. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)10003-x · Cited by 81
Jerlhag, E., Grøtli, M., Luthman, K., Svensson, L., & Engel, J. A. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl049 · Cited by 80
Rada, P. V., JOHNSON, D., LEWIS, M., & Hoebel, B. G. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.011 · Cited by 75
REVIEW: Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone
Oslin, D. W., Berrettini, W. H., & O’Brien, C. P. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00036.x · Cited by 67
Mecamylamine and Ethanol Preference in Healthy Volunteers
Young, E. M., Mahler, S. V., Chi, H., & de Wit, H. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000150007.34702.16 · Cited by 65
Stromberg, M. F., Volpicelli, J. R., & O'Brien, C. P. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb05932.x · Cited by 63
Owens, J. C., Balogh, S. A., McClure‐Begley, T. D., Butt, C. M., Labarca, C. G., Lester, H. A., Picciotto, M. R., Wehner, J. M., & Collins, A. C. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000102700.72447.0f · Cited by 56
Ethanol modulates nicotine-induced upregulation of nAChRs
Dohrman, D. P., & Reiter, C. K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02593-9 · Cited by 55
Interaction of the Nicotinic Cholinergic System with Ethanol Withdrawal
Butt, C. M., King, N. M., Stitzel, J. A., & Collins, A. C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059758 · Cited by 51
Potential regulation of nicotine and ethanol actions by α4-containing nicotinic receptors
Tritto, T., Marley, R. J., Bastidas, D., Stitzel, J. A., & Collins, A. C. (2001) · Alcohol · doi:10.1016/s0741-8329(01)00135-5 · Cited by 43
Effects of Ethanol on Excitatory and Inhibitory Synaptic Transmission in Rat Cortical Neurons
Moriguchi, S., Zhao, X., Marszalec, W., Yeh, J. Z., & Narahashi, T. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00266.x · Cited by 35
Stromberg, M. F., Rukstalis, M. R., Mackler, S. A., Volpicelli, J. R., & O’Brien, C. P. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00721-9 · Cited by 33
Perfumi, M. C., Santoni, M., Cippitelli, A., Ciccocioppo, R., Froldi, R., & Massi, M. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000092062.60924.56 · Cited by 30
Cited by
Schuckit, M. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60009-x · Cited by 712
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 634
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R., Rollema, H., & Bertrand, D. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 522
Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
McKee, S. A., Harrison, E. L. R., O'Malley, S. S., Krishnan-Sarin, S., Shi, J., Tetrault, J. M., Picciotto, M. R., Petrakis, I. L., Estevez, N., & Balchunas, E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.029 · Cited by 298
Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31829623f4 · Cited by 287
“Preclinical studies demonstrated decreases in alcohol consumption in rodents that were given varenicline (Steensland et al., 2007; Ericson et al., 2009; Wouda et al., 2011).”
Background
Metadata
- Authors
- Steensland, P., Simms, J. A., Holgate, J., Richards, J. K., & Bartlett, S. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-07-24
- Volume
- 104
- Issue
- 30
- Pages
- 12518-12523
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2016691339
- Cited by
- 365
- References
- 57
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.